Abstract:Pulmonary hypertension (PH), characterized by a progressive increase in pulmonary vascular resistance, leads to elevation of pulmonary arterial pressure and ultimately heart failure and death. Inhibition of ROCK signaling can effectively reverse the elevation in pulmonary vascular resistance. Fasudil, a specific ROCK inhibitor, has been reported to ameliorate PH in animal models, including PH induced by monocrotaline (MCT), Sugen5416/hypoxia and bleomycin. However, little information is available concerning the possible impact of fasudil on PH with left heart disease (PH-LHD). Rat models with PH-LHD were induced by supracoronary aortic banding for 63 day. Hemodynamics measurements were done by cardiac catheterization. Left lung tissues were fixed for H&E staining and the thickness of pulmonary artery walls were measured. QPCR were used to detect the mRNA levels and Elisa and Western Blot to evaluate the protein expressions. Supracoronary aortic banding for 63 days induced a great elevation of mean pulmonary pressure and right vitricular systolic pressure in rats, and treatment with fasudil (30mg/Kg/day, i.p.)for 4 weeks reversed the elevation. Ration of RV/(LV+S) down-regulated while (LV+S)/RV up-regulated in rat at day 63 after opration, compared to sham group, indicating that this operation induced PH models due to left heart disease in rats. Fasudil treatment attenuated the left ventricular hypertrophy and prevents pulmonary vascular remodeling in rat PH-LHD models. The expression of NO and ET1 in serum were detected by Elisa. ET1 expression enhanced while NO levels reduced in PH group, compared to sham rats. Fasudil treatment reversed ET-1 expression and NO content in comparison with PH group. Moreover, mRNA levels of ROCK1, Rho and ETA increased greatly in lungs of rat with PH-LHD, compared to that in sham rats, while decreased in Fasudil treated PH-LHD group. Supracoronary aortic banding for 63 days induced MYPT-1 phosphorylation in lungs and Fasudil treatment inhibited this process. The efﬁcacy of treatment with fasudil suggests that blockade of RhoA/ROCK signaling pathway may be a promising therapy for patients with PH-LHD

Fasudil protects against adriamycin-induced acute heart injury by inhibiting oxidative stress, apoptosis and cellular senescence.

The Rho Kinase Inhibitor, Fasudil, Ameliorates Diabetes-Induced Cardiac Dysfunction by Improving Calcium Clearance and Actin Remodeling

Effects of Fructose-1,6-diphosphate on Concentration of Calcium and Activities of Sarcoplosnic Ca2+-ATPase in Cardiomyocytes of Adriamycin-treated Rats.

Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms

Fasudil ameliorates the ischemia/reperfusion oxidative injury in rat hearts through suppression of myosin regulatory light chain/NADPH oxidase 2 pathway.

Fasudil Ameliorates the Ischemia/reperfusion Oxidative Injury in Rat Hearts Through Suppression of Myosin Regulatory Light Chain/nadph Oxidase 2 Pathway

Rho Kinase Inhibitor, Fasudil, Attenuates Contrast-induced Acute Kidney Injury.

Fasudil Preserves Lung Endothelial Function and Reduces Pulmonary Vascular Remodeling in a Rat Model of End-Stage Pulmonary Hypertension with Left Heart Disease

The Mechanism of Alleviation of Acute Myocardial Ischemia/reperfusion Injury in Rats by Fasudil

Fasudil Prevents Pulmonary Vascular Remodeling in a Rat Model of Pulmonary Hypertension with Left Heart

Cardiac-targeted Expression of Soluble Fas Attenuates Doxorubicin-Induced Cardiotoxicity in Mice.

Investigation of polysaccharide from Radix Aconiti Lateralis Preparata (Fuzi) cardio protective effect on doxorubicin-induced chronic cardiotoxicity

Anti-atherogenic Effect of Fasudil and Its Mechanisms

[Effect of fasudil of on rat cardiomyocytes acutely exposed to omethoate]

Exenatide alleviates adriamycin-induced heart dysfunction in mice: Modulation of oxidative stress, apoptosis and inflammation

Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection.

Anti-atherogenic Effects and Mechanism of Fasudil on ApoE~(-/-) Mice

Screen Identifies Fasudil As a Radioprotector on Human Fibroblasts

Protective Effect of Beta-CasomorPhin-7 on Oxidative Stress and Inflammatory Response in Adriamycin Cardiomyopathy

Rho kinase inhibitor fasudil protects against β-amyloid-induced hippocampal neurodegeneration in rats

Effects of Pyrrolidine Dithiocarbamate on Antioxidant Enzymes in Cardiomyopathy Induced by Adriamycin in Rats.